HPV vaccine cuts infections by 76%-98%, offers herd immunity
HPV vaccine shows 76%-98% effectiveness in preventing infections, including unvaccinated women.
Why it matters
- HPV vaccine is highly effective in real-world settings.
- Offers herd immunity, protecting unvaccinated women.
- Potential to eliminate cervical cancer globally.
By the numbers
- 2,335 participants in a 17-year study.
- HPV infections fell by 76%-98% among vaccinated women.
- Herd immunity reduced infections in unvaccinated women by 71.6%-75.8%.
The big picture
- HPV is a major cause of cervical cancer and other cancers.
- Global vaccination rates are low, with only 27% of girls receiving at least one dose.
- Expanding vaccination could eliminate cervical cancer.
What they're saying
- Personal anecdotes highlight the vaccine's effectiveness.
- Emphasis on the importance of widespread vaccination.
Caveats
- Study focused on Cincinnati.
- Global vaccination rates vary significantly.
What’s next
- Increase global vaccination rates.
- Continue monitoring and research on herd immunity effects.